Association of ABCB1 genetic variants with renal function in Africans and in Caucasians

Murielle Bochud1, Chin B Eap, Marc Maillard

  • 1Division of Nephrology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. Murielle.Bochud@chuv.ch

Insights

Genetic variants in the ABCB1 gene are linked to kidney function in both African and Caucasian populations. These ABCB1 gene variations may increase susceptibility to kidney disease, suggesting a new candidate gene for nephropathy.

Area of Science:

  • Genetics
  • Nephrology
  • Pharmacogenomics

Background:

  • P-glycoprotein, encoded by the ABCB1 gene, plays a role in regulating renal plasma flow and glomerular filtration rate.
  • ABCB1 gene expression is found in human endothelial and mesangial cells within the kidney.

Purpose of the Study:

  • To investigate the association between ABCB1 gene variants and renal function.
  • To examine these associations in both African and Caucasian populations.

Main Methods:

  • Genotyping of ABCB1 polymorphisms (2677G>T, 3435C>T) in African subjects and analysis of 30 SNPs in Caucasians using Affymetrix 500K chip data.
  • Measurement of glomerular filtration rate (GFR) and effective renal plasma flow (ERPF) in Africans; GFR estimation using MDRD and Cockcroft-Gault equations in Caucasians.

Main Results:

  • In Africans, specific ABCB1 alleles (2677T, 3435T) were associated with significantly higher GFR and ERPF, and lower renal resistance.
  • In Caucasians, three ABCB1 gene polymorphisms showed a strong association with all estimated GFR values, even after multiple testing correction.

Conclusions:

  • ABCB1 gene variants are associated with renal function in both African and Caucasian individuals.
  • These findings suggest that ABCB1 variants may confer susceptibility to nephropathy.
  • The ABCB1 gene emerges as a potential candidate gene for human nephropathy.
Abstract

Related Concept Videos

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...